SOX7 deficiency causes ventricular septal defects through its effects on endocardial-to-mesenchymal transition and the expression of Wnt4 and Bmp2

• Published in: Human molecular genetics 2023-06, Vol.32 (13), p.2152-2161
• Main Authors: Hernández-García, Andrés, Pendleton, Katherine E, Kim, Sangbae, Li, Yumei, Kim, Bum J, Zaveri, Hitisha P, Jordan, Valerie K, Berry, Aliska M, Ljungberg, M Cecilia, Chen, Rui, Lanz, Rainer B, Scott, Daryl A
• Format: Article
• Language: English
• Subjects: Animals; Endocardium - metabolism; Heart; Heart Defects, Congenital - genetics; Heart Septal Defects, Ventricular - genetics; Heart Septal Defects, Ventricular - metabolism; Mice; Myocardium - metabolism; Original; SOXF Transcription Factors - metabolism
• ISSN: 0964-6906; 1460-2083
• DOI: 10.1093/hmg/ddad050

Abstract SOX7 is a transcription factor-encoding gene located in a region on chromosome 8p23.1 that is recurrently deleted in individuals with ventricular septal defects (VSDs). We have previously shown that Sox7−/− embryos die of heart failure around E11.5. Here, we demonstrate that these embryos have hypocellular endocardial cushions with severely reduced numbers of mesenchymal cells. Ablation of Sox7 in the endocardium also resulted in hypocellular endocardial cushions, and we observed VSDs in rare E15.5 Sox7flox/−;Tie2-Cre and Sox7flox/flox;Tie2-Cre embryos that survived to E15.5. In atrioventricular explant studies, we showed that SOX7 deficiency leads to a severe reduction in endocardial-to-mesenchymal transition (EndMT). RNA-seq studies performed on E9.5 Sox7−/− heart tubes revealed severely reduced Wnt4 transcript levels. Wnt4 is expressed in the endocardium and promotes EndMT by acting in a paracrine manner to increase the expression of Bmp2 in the myocardium. Both WNT4 and BMP2 have been previously implicated in the development of VSDs in individuals with 46,XX sex reversal with dysgenesis of kidney, adrenals and lungs (SERKAL) syndrome and in individuals with short stature, facial dysmorphism and skeletal anomalies with or without cardiac anomalies 1 (SSFSC1) syndrome, respectively. We now show that Sox7 and Wnt4 interact genetically in the development of VSDs through their additive effects on endocardial cushion development with Sox7+/−;Wnt4+/− double heterozygous embryos having hypocellular endocardial cushions and perimembranous and muscular VSDs not seen in their Sox7+/− and Wnt4+/− littermates. These results provide additional evidence that SOX7, WNT4 and BMP2 function in the same pathway during mammalian septal development and that their deficiency can contribute to the development of VSDs in humans.